Search
Close this search box.

February 7, 2023

Keyron appoints new Chief Executive Officer

Carl D Francis takes the helm at medtech group focused on reversal of diabetes, NASH, and obesity LONDON, Feb. 07, 2023 (GLOBE NEWSWIRE) — Today Keyron, the medical technology group focused on reversing type 2 diabetes, non-alcoholic steatohepatitis (NASH), and

Reading more

Search Keywords

Search